NDC 70114-440-01

CIMERLI .3 mg/.05mL

ranibizumab-eqrn · INJECTION, SOLUTION

No Recall History

CIMERLI is a injection, solution containing ranibizumab-eqrn at a strength of .3 mg/.05mL. Manufactured by Coherus BioSciences Inc.

Key Facts

Brand Name: CIMERLI
Generic Name: ranibizumab-eqrn
NDC Code (Package): 70114-440-01
NDC Code (Product): 70114-440
Manufacturer: Coherus BioSciences Inc
Strength: .3 mg/.05mL
Dosage Form: INJECTION, SOLUTION
Route: INTRAVITREAL
Marketing Status
Application #: BLA761165
Drug Class: Vascular Endothelial Growth Factor Inhibitor [EPC]
Marketing Start: 10/03/2022

Recall History

No Recall History

View Full Drug Page

CIMERLI — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.